SH3YL1 and diabetic kidney disease: The expression of SH3YL1 in the serum of DKD patients, in kidney tissues of db/db mice, and in podocytes, is higher than control group, so it also has the potential as a biomarker for the diagnosis of DKD (Choi et al., 2021).